Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...

Assumptions of Survival Analysis

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.

The Mantel-Cox Log-Rank Test

The Mantel-Cox Log-Rank Test

The Mantel-Cox log-rank test is a widely used statistical method for comparing the survival distributions of two groups. It tests whether a statistically significant difference exists in survival times between the groups without assuming a specific distribution for the survival data, making it a non-parametric test. This flexibility makes the log-rank test particularly valuable in medical research and other fields where the timing of an event, such as death or disease recurrence, is of interest.

Introduction To Survival Analysis

Introduction To Survival Analysis

Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time until a...

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Parametric Survival Analysis: Weibull and Exponential Methods

Parametric Survival Analysis: Weibull and Exponential Methods

Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Risk, Predictors, and Outcomes of Acute Kidney Injury in Patients Admitted to Intensive Care Units in Egypt.

Scientific reports·2017

Same author

Long-Term Progression of Coronary Artery Calcification Is Independent of Classical Risk Factors, C-Reactive Protein, and Parathyroid Hormone in Renal Transplant Patients.

Cardiorenal medicine·2017

Same author

Obesity and kidney disease: Hidden consequences of the epidemic.

African journal of primary health care & family medicine·2017

Same author

Validation of echocardiographic criteria for the clinical diagnosis of heart failure in chronic kidney disease.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2017

Same author

Optimizing hypertension management in renal transplantation: a call to action.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2017

Same author

Optimizing hypertension management in renal transplantation: a call to action.

Journal of hypertension·2017

Same journal

Proceedings of the 5th Annual UAB-UCSD O'Brien Center Symposium, March 4, San Diego, California.

Nephron. Clinical practice·2015

Same journal

Proceedings of the 19th International Conference on Continuous Renal Replacement Therapies, March 2-3, 2014, San Diego, California, USA.

Nephron. Clinical practice·2015

Same journal

Chronic kidney disease in disadvantaged populations.

Nephron. Clinical practice·2015

Same journal

Differential membrane expression of Toll-like receptors and intracellular cytokine induction in peripheral blood monocytes of patients with chronic kidney disease and diabetic nephropathy.

Nephron. Clinical practice·2015

Same journal

Correction of hyper- and hyponatraemia during continuous renal replacement therapy.

Nephron. Clinical practice·2015

Same journal

Ectopic expression of fatty acid-binding protein 4 in the glomerulus is associated with proteinuria and renal dysfunction.

Nephron. Clinical practice·2015

See all related articles

Search research articles

Related Experiment Video

Updated: May 29, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

Survival analysis II: Cox regression.

Vianda S Stel¹, Friedo W Dekker, Giovanni Tripepi

¹ERA-EDTA Registry, Department of Medical Informatics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. v.s.stel@amc.uva.nl

Nephron. Clinical Practice

|September 17, 2011

Summary

This summary is machine-generated.

Cox proportional hazards regression offers survival analysis insights beyond Kaplan-Meier, quantifying survival differences and adjusting for confounders. This method provides effect estimates and guidance on result presentation for clinical research.

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

Related Experiment Videos

Last Updated: May 29, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

An R-Based Landscape Validation of a Competing Risk Model

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

Area of Science:

Biostatistics
Survival Analysis
Clinical Research Methodology

Background:

The Kaplan-Meier method is a standard for survival analysis.
Limitations exist in quantifying survival differences and adjusting for covariates.

Purpose of the Study:

To explain the fundamental principles of Cox proportional hazards regression.
To offer guidance on effectively presenting Cox regression results.

Main Methods:

Explains Cox proportional hazards regression.
Contrasts with Kaplan-Meier method.
Focuses on effect estimation and covariate adjustment.

Main Results:

Cox regression provides quantifiable survival differences between groups.
It allows adjustment for confounding variables.
Offers a more comprehensive analysis than Kaplan-Meier alone.

Conclusions:

Cox proportional hazards regression is a powerful tool for survival data analysis.
It enhances understanding of treatment effects and patient outcomes.
Proper result presentation is crucial for accurate interpretation.